UNSPSC 51152061: Lanperisone hydrochloride

This classification denotes a muscle relaxant with the molecular formula C15H18F3NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JRF22NV56M, chemically known as (-)-lanperisone hydrochloride, but more generally known as lanperisone hydrochloride, which bears US NIH Compound Identifier 198706. European Medicines Agency schedules lanperisone hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08400MIG.

Most nations, for tariff purposes, schedule lanperisone hydrochloride under HS 29339990. SMILES: C[C@H](CN1CCCC1)C(=O)C2CCC(CC2)C(F)(F)F.CL.

UNSPSC 51152061 Lanperisone hydrochloride (Commodity) represents pharmaceutical products purchased by state and local health and safety agencies, though recent solicitations under this code show minimal direct activity. The single recent opportunity in the procurement record reflects a substantial mismatch: Seminole County, Florida's IFB 60459723LAS solicited naloxone and drug deactivation systems—emergency medical countermeasures and harm-reduction equipment—rather than lanperisone hydrochloride, a muscle relaxant pharmaceutical. Issuing bodies pursuing work under this code span county health departments and community health initiatives, typically through competitive bidding (IFB) with delivery requirements specified to named health facilities and quarterly fulfillment schedules.

Seminole County's procurement (posted June 30, 2026; response deadline July 26, 2023) required annual delivery of 1,900 units of naloxone and 800 safe drug deactivation systems to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for shipping and handling costs. The contract included a two-year initial term with one-year renewal option, fixed-fee pricing, and standard compliance requirements (drug-free workplace certification, E-Verify, workers' compensation and commercial general liability insurance). The procurement flagged potential FEMA funding and associated federal compliance obligations. The code shows limited recent state and local solicitation activity under its nominal pharmaceutical scope; buyers pursuing naloxone and related emergency medical products typically tag them under different UNSPSC classifications focused on medical supplies and emergency response equipment.